Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ceribell (CBLL) Research & Development (2023 - 2025)

Ceribell (CBLL) has disclosed Research & Development for 3 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 29.36% year-over-year to $5.1 million, compared with a TTM value of $19.1 million through Dec 2025, up 41.15%, and an annual FY2025 reading of $19.1 million, up 41.15% over the prior year.
  • Research & Development was $5.1 million for Q4 2025 at Ceribell, up from $5.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $5.1 million in Q4 2025 and bottomed at $2.7 million in Q4 2023.
  • Average Research & Development over 3 years is $3.9 million, with a median of $3.9 million recorded in 2024.
  • Peak annual rise in Research & Development hit 48.38% in 2025, while the deepest fall reached 29.36% in 2025.
  • Year by year, Research & Development stood at $2.7 million in 2023, then skyrocketed by 45.57% to $3.9 million in 2024, then rose by 29.36% to $5.1 million in 2025.
  • Business Quant data shows Research & Development for CBLL at $5.1 million in Q4 2025, $5.0 million in Q3 2025, and $4.9 million in Q2 2025.